endpoint and Berlinger Collaborate to Provide Complete Visibility of the Historical Temperature Journey of an IMP
Fully integrated solution: Turn a 25-day manual temperature-monitoring data evaluation into instant decision making SAN FRANCISCO and SWITZERLAND, Oct. 6, 2021 /PRNewswire/ -- endpoint Clinical, the leader in global interactive response technology (IRT®) for clinical trials, and Berlinger & Co. AG, specializing in the production of innovative and customized solutions for monitoring...
Kazia Therapeutics to Present at LD Micro Main Event
SYDNEY, Oct. 6, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, Dr James Garner, will be presenting at the LD Micro Main Event, to be held virtually and in person from 12-14 October 2021. Since 2008, the LD Micro Main Event has established itself as one of...
ASEAN leaders convene in Special Ministerial Conference to shape resilient healthcare systems through regional collaboration
Renewed lockdowns and the COVID-19 Delta variant outbreak have impacted the economic recovery of ASEAN-5 – comprising Malaysia, Thailand, Vietnam, Indonesia, and the Philippines Organised by EVYD Knowledge Hub, in collaboration with the Ministry of Finance and Economy in Brunei Darussalam, Ministry of Health in Brunei Darussalam, Brunei Investment Agency and Temasek Foundation, the conference gathers over 50...
BICO launches the S.NEST, a high throughput microbioreactor with real-time monitoring to ensure maximum cell growth and streamlined workflows
TAIPEI, Oct. 6, 2021 /PRNewswire/ -- CYTENA Bioprocess Solutions, a BICO company, has launched the S.NEST™, a state-of-the art microbioreactor that maximizes cell growth while monitoring and analyzing cell conditions from start to finish. Well-known for combining innovative bioscience technologies with best-in-class software development, CYTENA Bioprocess Solutions has developed their new microbioreactor...
ArisGlobal LifeSphere® MultiVigilance is selected by Asahi Kasei Pharma
MIAMI and TOKYO, Oct. 6, 2021 /PRNewswire/ -- Asahi Kasei Pharma Corp. has selected LifeSphere® MultiVigilance as a new safety database with the purpose of building a system that supports efficiency, regulatory compliance, and global collaboration over the long term. In addition, Asahi Kasei Pharma will adopt ArisGlobal's rapid migration methodology, which has been...
Plano publishes global evidence linking digital device screen time with myopia (short-sightedness) in The Lancet Digital Health today
SINGAPORE, Oct. 6, 2021 /PRNewswire/ -- A major global study linking the use of digital smart devices (smartphones and tablets) with myopia in children was released today by an international collaboration led by researchers in Singapore. The study - a comprehensive systematic review and meta-analysis - also included world experts in eye health and epidemiology from Australia, the UK,...
146th Annual Meeting of the American Neurological Association to Focus on Research and Development of Neurologic Disease Therapeutics
World's Leading Academic Neurologists and Neuroscientists to Present at ANA2021 MOUNT LAUREL, N.J., Oct. 6, 2021 /PRNewswire/ -- This year's Virtual Annual Meeting, ANA2021 will welcome more than 1,000 academic neurologists and neuroscientists from around the world to share exciting research updates and best practices as they explore the latest research and developments in therapeutics related to inherited and...
VUNO Signs Another Deal with Samsung Electronics to Incorporate AI-assisted Solutions into Samsung’s Premium Ceiling Type Digital Radiography System
SEOUL, South Korea, Oct. 5, 2021 /PRNewswire/ -- South Korean artificial intelligence (AI) developer, VUNO Inc., announced today that the company closed a deal with global medical device manufacturer, Samsung Electronics Co., Ltd., to embed VUNO's artificial intelligence-driven chest X-ray diagnostic solution, VUNO Med®-Chest X-ray™ into Samsung's GC85A premium ceiling type digital radiography system. VUNO Med®-Chest...
Renexxion Ireland Ltd. Announces a Licensing and Collaboration Agreement with Dr. Falk Pharma GmbH
ROSCREA, Ireland and FREIBURG, Germany, Oct. 5, 2021 /PRNewswire/ -- Renexxion Ireland Ltd., a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need gastrointestinal ("GI") disorders, announced today that it has entered into a Licensing and Collaboration Agreement with Dr. Falk Pharma GmbH to jointly develop and commercialize Naronapride, a unique late-stage GI...
I-Mab and ABL Bio to Present Preclinical Data of TJ-CD4B/ABL111 and TJ-L14B/ABL503 at the 2021 SITC Annual Meeting
SHANGHAI and GAITHERSBURG, Md., Oct. 5, 2021 /PRNewswire/ -- I-Mab (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics, and ABL Bio, Inc. (Kosdaq:298380, hereafter "ABL"), a South Korean biotech specializing in bispecific antibody technology, jointly announced that data from the preclinical studies of...
